Quality of Life Analysis of N0877 (Alliance): Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM)
- Citation:
- J Clin Oncol vol 33 (suppl) abstr e17715
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Published Only
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- Neuro-Onc
- Pharmas:
- Grants:
- Corr. Author:
- Rui Qin
- Authors:
- Rui Qin Angelina D. Tan Jeff A. Sloan Derek Richard Johnson Glenn Jay Lesser S. Keith Anderson Nadia N. Laack
- Networks:
- LAPS-MN026, NC002
- Study
- NCCTG-N0877
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: